Page last updated: 2024-08-24
2,5-dimethoxy-4-bromoamphetamine and Cancer of Pituitary
2,5-dimethoxy-4-bromoamphetamine has been researched along with Cancer of Pituitary in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Grotewiel, MS; Sanders-Bush, E | 1 |
Other Studies
1 other study(ies) available for 2,5-dimethoxy-4-bromoamphetamine and Cancer of Pituitary
| Article | Year |
|---|---|
Regulation of serotonin2A receptors in heterologous expression systems.
Topics: 3T3 Cells; Animals; Antiparkinson Agents; Binding, Competitive; Cell Line; Dogs; DOM 2,5-Dimethoxy-4-Methylamphetamine; Ergolines; Gene Expression Regulation; Ketanserin; Kidney; Kinetics; Mice; Pituitary Neoplasms; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Recombinant Proteins; Transfection; Tumor Cells, Cultured | 1994 |